Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:06 a.m.

    📋 IMMUNOVANT, INC. (IMVT) - Financial Results

    Filing Date: 2022-06-08

    Accepted: 2022-06-08 07:05:32

    Event Type: Financial Results

    Event Details:

    Immunovant Inc (IMVT) Reports Q2 2022 Financial Results Immunovant Inc (IMVT) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: $494 million
      • expected in the first half of calendar year 2025
      • expected in the second half of calendar year 2024
      • targeting the neonatal Fc receptor (FcRn). For additional information on the Company, please visit www.immunovant.com. Forward-Looking StatementsThis press release contains forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Net Loss 28.16K 156.73K $-128.57K -82.03%
    Current Assets Prepaid Expenses Other Current Assets 6.25K 7.72K $-1.46K -18.96%
    Current Assets Operating Lease Right Of Use Assets 2.30K 3.28K $-979.00 -29.83%
    Current Assets Property Equipment Net 330.00 201.00 $129.00 +64.18%
    Current Liabilities Accounts Payable 18.63K 18.63K $0.00 +0.00%
    Net Loss 47.17K 47.17K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 6.25K 7.72K $-1.46K -18.96%
    Property and Equipment, Net 330.00 201.00 $129.00 +64.18%
    Accounts Payable 18.63K 18.63K $0.00 +0.00%
    Operating Lease Liabilities 1.15K 1.18K $-34.00 -2.88%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Immunovant Inc
    • CIK: 0001764013
    • Ticker Symbol: IMVT
    • Period End Date: 2022-06-08
    • Document Type: 8-K

Search

News categories